The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Psoriatic Arthritis Treatment Market Research Report 2025

Global Psoriatic Arthritis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1907852

No of Pages : 81

Synopsis
The global Psoriatic Arthritis Treatment market was valued at US$ 7910.7 million in 2023 and is anticipated to reach US$ 12040 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Treatment.
Report Scope
The Psoriatic Arthritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health
Segment by Type
Kits
Reagents
Instruments
Segment by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits
1.2.3 Reagents
1.2.4 Instruments
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Treatment Market Perspective (2019-2030)
2.2 Psoriatic Arthritis Treatment Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Psoriatic Arthritis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Psoriatic Arthritis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Psoriatic Arthritis Treatment Market Dynamics
2.3.1 Psoriatic Arthritis Treatment Industry Trends
2.3.2 Psoriatic Arthritis Treatment Market Drivers
2.3.3 Psoriatic Arthritis Treatment Market Challenges
2.3.4 Psoriatic Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Treatment Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Treatment Players by Revenue (2019-2024)
3.1.2 Global Psoriatic Arthritis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Psoriatic Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Treatment Revenue
3.4 Global Psoriatic Arthritis Treatment Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Revenue in 2023
3.5 Psoriatic Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Treatment Breakdown Data by Type
4.1 Global Psoriatic Arthritis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Type (2025-2030)
5 Psoriatic Arthritis Treatment Breakdown Data by Application
5.1 Global Psoriatic Arthritis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Psoriatic Arthritis Treatment Market Size (2019-2030)
6.2 North America Psoriatic Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Psoriatic Arthritis Treatment Market Size by Country (2019-2024)
6.4 North America Psoriatic Arthritis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Treatment Market Size (2019-2030)
7.2 Europe Psoriatic Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Psoriatic Arthritis Treatment Market Size by Country (2019-2024)
7.4 Europe Psoriatic Arthritis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Psoriatic Arthritis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Psoriatic Arthritis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Psoriatic Arthritis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis Treatment Market Size (2019-2030)
9.2 Latin America Psoriatic Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Psoriatic Arthritis Treatment Market Size by Country (2019-2024)
9.4 Latin America Psoriatic Arthritis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Psoriatic Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Psoriatic Arthritis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Psoriatic Arthritis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Psoriatic Arthritis Treatment Introduction
11.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Psoriatic Arthritis Treatment Introduction
11.2.4 Roche Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Psoriatic Arthritis Treatment Introduction
11.3.4 Merck Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis Treatment Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Detail
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Psoriatic Arthritis Treatment Introduction
11.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.5.5 Abbvie Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Psoriatic Arthritis Treatment Introduction
11.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Detail
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Introduction
11.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Detail
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Psoriatic Arthritis Treatment Introduction
11.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.8.5 Celgene Corporation Recent Development
11.9 Janssen
11.9.1 Janssen Company Detail
11.9.2 Janssen Business Overview
11.9.3 Janssen Psoriatic Arthritis Treatment Introduction
11.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.9.5 Janssen Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Detail
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Psoriatic Arthritis Treatment Introduction
11.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Business (2019-2024)
11.10.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’